Skip to main content

4 Result(s)

within **gxiang Guo Remove this filter Oncology Remove this filter Surgical Oncology Remove this filter

and

  1. No Access

    Article

    ASO Visual Abstract: Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial

    Qihan Fu MD, Yiwen Chen MD, Dabing Huang MS… in Annals of Surgical Oncology (2023)

  2. No Access

    Article

    Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial

    Folinic acid, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) or modified FOLFIRINOX (mFFX) is the first-line standard of care for metastatic pancreatic adenocarcinoma; effective and safe treatment stra...

    Qihan Fu MD, Yiwen Chen MD, Dabing Huang MS… in Annals of Surgical Oncology (2023)

  3. Article

    Open Access

    Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgery

    With the advent of intensive combination regimens, an increasing number of patients with unresectable pancreatic cancer (UPC) have regained the opportunity for surgery. We investigated the clinical benefits an...

    **ang Li, **nyuan Liu, Na Lu, Yiwen Chen, **aochen Zhang, Chengxiang Guo… in BMC Cancer (2023)

    Download PDF (1422 KB) View Article

  4. Article

    Open Access

    A preoperative nomogram predicts prognosis of patients with hepatocellular carcinoma after liver transplantation: a multicenter retrospective study

    Although criteria for liver transplantation, such as the Milan criteria and Hangzhou experiences, have become popular, criteria to guide adjuvant therapy for patients with hepatocellular carcinoma after liver ...

    Dabing Huang, Yinan Shen, Wei Zhang, Chengxiang Guo, Tingbo Liang, Xueli Bai in BMC Cancer (2021)

    Download PDF (645 KB) View Article